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Abstract Prostaglandin E2 (PGE2) is the major vasodila-
tor prostanoid of the mammalian ductus arteriosus (DA). In
the present study we analyzed the response of isolated DA
rings from 15-, 19- and 21-day-old chicken embryos to
PGE2 and other vascular smooth muscle relaxing agents
acting through the cyclic AMP signaling pathway. PGE2
exhibited a relaxant response in the 15-day DA, but not in
the 19- and 21-day DA. Moreover, high concentrations of
PGE2 (¸3 M in 15-day and ¸1 M in 19-day and 21-day
DA) induced contraction of the chicken DA. The presence
of the TP receptor antagonist SQ29,548, unmasked a relax-
ant eVect of PGE2 in the 19- and 21-day DA and increased
the relaxation induced by PGE2 in the 15-day DA. The
presence of the EP receptor antagonist AH6809 abolished
PGE2-mediated relaxation. The relaxant responses induced
by PGE2 and the -adrenoceptor agonist isoproterenol, but
not those elicited by the adenylate cyclase activator for-
skolin or the phosphodiesterase 3 inhibitor milrinone,
decreased with maturation. High oxygen concentrations
(95%) decreased the relaxation to PGE2. The relaxing
potency and eYcacy of isoproterenol and milrinone were
higher in the pulmonary than in the aortic side of the DA,
whereas no regional diVerences were found in the response
to PGE2. We conclude that, in contrast to the mammalian
situation, PGE2 is a weak relaxant agent of the chicken DA
and, with advancing incubation, it even stimulates TP vaso-
constrictive receptors.
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Introduction
The ductus arteriosus (DA), a fetal arterial connection
between the pulmonary artery and the descending aorta, is
indispensable for fetal life. Considerable evidence supports a
major role for the cyclooxygenase (COX) product prosta-
glandin (PG) E2 in maintaining mammalian fetal patency and
for the rapid decline in PGE2 levels as trigger of DA closure
after birth (see Clyman 2006; Smith 1998 for reviews).
In blood vessels, PGE2 acts on four diVerent prostanoid
receptors: EP1, EP2, EP3 and EP4. Both EP2- and EP4-receptor
subtypes mediate PGE2 relaxation through a cyclic AMP-
dependent mechanism (Narumiya and FitzGerald 2001). EP1 is
a constrictive receptor and EP3 induces a decline in cAMP,
inhibiting smooth muscle relaxation (Narumiya and FitzGerald
2001). The main receptor responsible for PGE2-induced DA
relaxation varies among mammalian species and was reported
as EP4 in rabbits (Smith 1998; Smith et al. 1994; Smith and
McGrath 1995), mice (Nguyen et al. 1997), rats (Kajino et al.
2004), lambs (Waleh et al. 2004), baboon (Waleh et al. 2004),
and humans (Leonhardt et al. 2003), and as EP2 in pigs
(Bhattacharya et al. 1999) and lambs (Bouayad et al. 2001).
The cAMP-inhibiting EP3 receptor is also present in the rabbit
and piglet DA, modulating the dilating eVect of PGE2
Communicated by H.V. Carey.
P. Ågren · S. van der Sterren · C. E. Blanco · E. Villamor (&)
Department of Pediatrics, 
Maastricht University Medical Center (MUMC+), 
Research Institute Growth and Development (GROW), 
University Hospital Maastricht, P. Debyelaan 25, 
P.O. Box 5800, 6202 AZ Maastricht, The Netherlands
e-mail: eiv@paed.azm.nl
A. L. Cogolludo
Department of Pharmacology, School of Medicine, 
Universidad Complutense, CIBER Enfermedades 
Respiratorias (CibeRes), 28040 Madrid, Spain123
134 J Comp Physiol B (2009) 179:133–143(Bhattacharya et al. 1999; Smith 1998; Smith et al. 1994;
Smith and McGrath 1995). In contrast, stimulation of EP3
receptor in the lamb DA produces not contraction but relaxa-
tion via a cAMP-independent pathway (Bouayad et al. 2001).
SigniWcant progress in our understanding of the ductal
eVects of PGE2, as well as other aspects of DA physiology
and pathophysiology, has been achieved with the use of
mammalian models (Sutendra and Michelakis 2007). How-
ever, these models are technically complex and experimen-
tal manipulations aVect both the mother and the fetus.
Therefore, there is a need for additional models, addressing
these limitations (Sutendra and Michelakis 2007).
Recently, we analyzed the ontogeny of the chicken DA
response to O2 and other vasoconstrictors (Agren et al.
2007), as well as the relaxation induced by agonists acting
through the nitric oxide (NO)-soluble guanylate cyclase
(sGC)-cyclic GMP (cGMP) pathway (Agren et al. 2008).
We found that the eVects of vasoactive mediators on
chicken DA tone are developmentally regulated with loss
of responsiveness to vasodilators and increase of respon-
siveness to vasoconstrictors with advancing incubation age.
Most of the physiological functions that prostanoids
exhibit in mammals seem to be present in avian and other
non-mammalian vertebrates (Rowley 1991). Prostanoids
are produced in chicken blood vessels and participate in the
regulation of vascular tone (Chand and Eyre 1976; Claeys
et al. 1981; Wideman et al. 1999). However, we have
observed that in the chicken DA COX inhibitors did not
produce signiWcant contractile eVects (Agren et al. 2007)
and did not aVect endothelium-dependent relaxation (Agren
et al. 2008), suggesting that locally produced PGs are not
important mediators in the control of chicken ductal tone.
Accordingly, Dzialowski and Greyner (2008) demonstrated
that COX inhibition did not produce any change in the
basal tension of DA of another avian species, the emu.
However, they also observed that the emu DA was relaxed
by exogenous PGE2 (Dzialowski and Greyner 2008). This
indicates that PGE2, the most potent vasodilator in the regu-
lation of mammalian DA tone, is also active in the avian
DA. In the present study we hypothesized that the chicken
DA is responsive to PGE2 and that its responsiveness is
developmentally regulated. Therefore, we analyzed, at
diVerent ages, the ex vivo response of chicken DA to PGE2
and other vascular smooth muscle relaxing agents acting
through the cAMP signaling pathway.
Material and methods
Embryos incubation and vessel isolation
Experiments were performed in accordance with Dutch law
for animal experimentation. Fertilized eggs of White
Leghorn chickens were incubated at 37.8°C, 45% humidity
and rotated once per hour (Incubator model 25HS, Masalles
Comercial, Spain). Embryos incubated for 15, 19 and
21 days of the 21-day incubation period were studied. The
majority of the experiments were performed in 19-day
(non-internally pipped) embryos, while for the study of
developmental changes all three ages were compared (see
below). On the experimental day the embryos were killed
by decapitation and the right DA was carefully dissected
free and severed distal to the takeoV of the right pulmonary
artery and proximal to the insertion into the dorsal aorta.
The average in situ length (in mm) of the right DA was 3.48
(SD 0.27), 4.71 (SD 0.40), and 5.58 (SD 0.40) at embryonic
day 15, 19, and 21, respectively, (Agren et al. 2007),
whereas the maximal length allowed in the myograph was
2 mm. Therefore, a similar length of ductal tissue was
removed from the pulmonary and aortic ends of the vessel
to obtain a segment of the central part of the DA with a
length of approximately 2 mm. The right DA was selected
because its shorter length allowed having a higher propor-
tion of the vessel represented in the myograph.
Recording of arterial reactivity
Two stainless steel wires (diameter 40 m) were inserted
into the lumen of the DA, which was mounted as a ring seg-
ment between an isometric force transducer and a displace-
ment device in a myograph (Danish Myo Technology A/S
model 610 M, Aarhus, Denmark). The myograph organ
bath (5 mL vol) was Wlled with Krebs–Ringer bicarbonate
(KRB) buVer maintained at 39°C and continuously
aerated with one of the following gas mixtures: 0% O2/95%
N2/5% CO2 (pO2 = 2.6–3.3 kPa), 5% O2/90%N2/5% CO2
(pO2 = 6.8–7.2 kPa), or 95% O2/5% CO2 (pO2 = 72–
76 kPa). The Wnal pH was 7.38–7.42 and pCO2 was 4.6–
5.6 kPa in all solutions. Each DA was stretched to its
individual optimal lumen diameter, i.e., the diameter at
which it developed the strongest contractile response to
62.5 mM K+, using a diameter-tension protocol as previ-
ously described (Agren et al. 2007; Villamor et al. 2002).
During the Wrst phase of stabilization and determination of
optimal diameter, DA rings were maintained in KRB buVer
with a pO2 of »3 kPa. Afterward, oxygen concentration
was switched to 5% (pO2 »7 kPa), unless the eVect of O2
on the relaxant responses was evaluated. When two or more
agonists were studied in the same arterial preparation, the
vessels were repeatedly washed and allowed to equilibrate
for at least 30 min. If the tone did not recover to resting
level or 62.5 mM K+ failed to induce an adequate level of
contraction, the vessels were discarded for further experi-
ments.
The eVects of PGE2 (0.1 nM–10 M), the direct activator of
adenylate cyclase forskolin (0.1–10 M), the -adrenoceptor123
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terase 3 (PDE3) inhibitor milrinone (0.1 M–0.1 mM) were
evaluated in DA rings contracted with K+ (62.5 mM), or the
thromboxane (Tx)A2-mimetic (selective TP-receptor ago-
nist) U46619 (0.1 M). When stable contractions were
obtained, agonists were added cumulatively to the bath
until a maximal response was achieved. In some experi-
ments, the relaxation evoked by PGE2 was studied in the
presence of the TP-receptor antagonist SQ29,548 (10 M),
or the non-selective EP receptor antagonist AH6809 (6-iso-
propoxy-9-oxoxanthene-2-carboxylic acid; 10 M) and the
relaxations evoked by isoproterenol and forskolin were
studied in the presence of the non-selective COX inhibitor
indomethacin (10 M), the COX-1 inhibitor valeryl
salicylate (0.5 mM), or the COX-2 inhibitor nimesulide
(0.1 M).
In order to analyze developmental changes on relaxa-
tion, the responses to PGE2, forskolin, isoproterenol, and
milrinone were studied in the central part of DA from 15-,
19-, and 21-day-old embryos. The 21-day embryos were
externally pipped for about 1-3 h. In another set of experi-
ments, aimed to evaluate the modulatory role of O2 in DA
relaxation, the responses to PGE2, were studied under three
diVerent conditions of pO2: »3, 7, and 74 kPa. In these
experiments, optimal diameter was determined at 3 kPa.
Thereafter the O2 concentration was switched to the appro-
priate level and the vessels were allowed to equilibrate for
at least 30 min before the concentration- response curve for
the agonists was obtained. Finally and in order to analyze
the diVerences along the DA in the responses to PGE2, for-
skolin, isoproterenol, milrinone and U46619, we performed
a third set of experiments in which the pulmonary and the
aortic parts of the vessel were compared in 19-day
embryos. The responses to U46619 and milrinone were also
analyzed in the pulmonary and the aortic parts of the DA
from 15-day embryos. The boundary between pulmonary
and aortic segments was determined during the dissection
based on the marked diVerences of diameter observed along
the chicken DA (see Agren et al. 2007).
Data analysis
Results are shown as mean (SD) of measurements in n
embryos. For clarity, results are shown in the Wgures as
mean § SE. Contractions are expressed in terms of active
wall tension (N/m), calculated as the force divided by twice
the length of the segment, while the relaxant responses are
expressed as the percentage of reduction of the contraction
induced by K+, or U46619. Sensitivity (expressed as
pD2 = ¡log EC50) and maximal relaxation (Emax) to ago-
nists was determined for each artery by Wtting individual
concentration–response data to a non-linear sigmoidal
regression curve and interpolating (Graphpad Prism version
2.01; GraphPad Software Inc, San Diego, CA, USA). When
a maximal response was not achieved with a given agonist,
the regression curve could not be calculated and the
responses for each concentration of the agonist were used
for comparison. DiVerences between mean values were
assessed by one-way ANOVA followed by Bonferroni post
hoc t test. Non-paired t tests were used if only two groups
were compared. DiVerences were considered signiWcant at
a P < 0.05. All analyses were performed using a commer-
cially available statistics package (GraphPad InStat version
3.00; GraphPad Software Inc, San Diego, CA, USA).
Drugs and solutions
PGE2, U46619, SQ29,548, and AH6809 were obtained
from Cayman Chemical (Ann Arbor, MI, USA). Valeryl
salicylate, nimesulide, and milrinone were obtained from
Alexis Biochemicals (Lausen, Switzerland). All the other
drugs were obtained from Sigma Chemical Co (St Louis,
MO, USA). PGE2, U46619, and AH6809 were dissolved in
DMSO and SQ29,548 indomethacin, valeryl salicylate,
nimesulide and milrinone in ethanol to prepare adequate
stock solutions and further dilutions were made in KRB.
The Wnal bath concentration of DMSO and ethanol did not
exceed 0.1%, which we have found elsewhere to have little
or no eVect on mechanical activity (Agren et al. 2007). All




Isolated DA obtained from 15-, 19- and 21-day chicken
embryos responded to depolarizing high-K+ (62.5 mM)
solution with a tonic contraction and this response signiW-
cantly increased with age (15-day: 0.21 N/m, SD 0.05,
n = 30, P < 0.001 from both 19 and 21-day; 19-day: 0.61 N/
m, SD 0.19, n = 69; 21-day: 0.99 N/m, SD 0.37, n = 21,
P < 0.001 from 19-day old.). The diameter at which a max-
imal response to 62.5 mM KCl was obtained increased
between day 15 (787 m, SD 89, n = 30) and 19 (830 m,
SD 121, n = 69, P < 0.001 vs.15-day), but decreased at day
21 (483 m, SD 227, n = 21, P < 0.001 vs.15- and 19-day).
EVects of PGE2 in chicken DA
In the Wrst set of experiments we tested the relaxant eVects
induced by PGE2 in chicken DA stimulated with KCl
62.5 mM. We found that PGE2 exhibited a relaxant
response in 15-day DA (Figs. 1a, 2a; Table 1), but no sig-
niWcant relaxation was observed in 19- and 21-day DA123
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PGE2 (¸3 M in 15-day and ¸1 M in 19- and 21-day DA)
induced contraction of the chicken DA (Figs. 1a, b, 2a).
The presence of the TP receptor antagonist SQ29,548,
unmasked a relaxant eVect of PGE2 in the 19- (Figs. 1c, 2b;
Table 1) and 21-day DA (Fig. 2b; Table 1) and increased
the relaxation induced by PGE2 in the 15-day DA (Fig. 2b;
Table 1). Under these conditions (i.e., presence of
SQ29,548), the maximal relaxant response induced by
PGE2 was reduced in term (externally pipped 21-day) ver-
sus preterm (non-internally pipped 15-day and 19-day)
chicken DA, while the sensitivity to PGE2 was not aVected
by age (Table 1). When the 19-day DA was contracted with
the TP receptor agonist U46619 (0.1 M), PGE2 induced a
concentration-dependent relaxation with a threshold con-
centration of 1 nM (Figs. 1d, 2d) and without achieving the
maximal eVect with the highest concentration tested
(10 M). The presence of the EP receptor antagonist
AH6809 reduced the contraction induced by U46619 from
0.8 N/m (SD 0.11, n = 6) to 0.58 N/m (SD 0.12, n = 6,
P < 0.01 vs. control) and abolished PGE2-mediated relaxa-
tion of U46619-contracted DA (Fig. 2d). As shown in
Fig. 2c, bubbling the organ chamber with 95% O2 (pO2
»74 kPa) produced a marked reduction of the relaxation
evoked by PGE2 in 19-day DA (contracted with
62.5 mM K+ and in the presence of SQ29,548).
Relaxant eVects of isoproterenol, forskolin, and milrinone 
in chicken DA
In K+-stimulated DA, the addition of the -adrenoceptor
agonist isoproterenol, the direct activator of adenylate
cyclase forskolin, or the PDE3 inhibitor milrinone caused a
concentration-dependent relaxation (Fig. 3a, c, e; Table 1).
As expected the -adrenergic receptor blocker propanolol
drastically reduced the relaxation response induced by iso-
proterenol (Fig. 3a). Similar to PGE2, the relaxation
induced by isoproterenol was markedly diminished in 21-
day versus 15- or 19-day chicken DA (Fig. 3a). In contrast,
the relaxant eVect of forskolin did not change with age
(Fig. 3c; Table 1) and milrinone was less potent (but simi-
larly eYcacious) in relaxing the 15-day than the 19-, or 21-
day chicken DA (Fig. 3e; Table 1). Finally, as shown in
Fig. 3b and d, the relaxation evoked by isoproterenol and
forskolin were not signiWcantly aVected by the presence of
the COX inhibitors indomethacin, valeryl salicylate, or
nimesulide, compared to control vessels (incubated with
vehicle, ethanol 0.1%).
Heterogeneity of relaxant responses along the DA
In the last set of experiments the responses to the drugs
studied above were compared in the pulmonary versus the
aortic side of the DA. The contractions induced by KCl
were not signiWcantly diVerent when the pulmonary and the
aortic side of the DA from the 19-day (pulmonary: 0.72 N/
m, SD 0.16, n = 14; aortic: 0.67 N/m, SD 0.2, n = 14) and
15-day embryos (pulmonary: 0.21 N/m, SD 0.03, n = 6;
aortic: 0.24 N/m, SD 0.05, n = 6) were compared. Simi-
larly, the optimal diameters were not signiWcantly diVerent
between the pulmonary and the aortic side of the 19-day
DA (pulmonary: 889 m, SD 88, n = 14; aortic: 936 m,
SD 87, n = 14) and 15-day DA (pulmonary: 742 m, SD
Fig. 1 Typical tracings illustrating the vascular eVects of prostaglan-
din E2 (PGE2) in chicken DA. During contraction induced by K+
(62.5 mM), PGE2 induced a concentration-dependent relaxation of the
15-day DA (a) but a contraction of the 19-day DA (b). In the presence
of the TP receptor antagonist SQ 29,548 (10 M, c) or when the vessel
was contracted with the TP receptor agonist U46619 (0.1 M, d), a
relaxant eVect of PGE2 was observed in the 19-day DA
















































J Comp Physiol B (2009) 179:133–143 13738, n = 6; aortic: 792 m, SD 49, n = 6). As shown in
Fig. 4a, the relaxation induced by PGE2 (vessels were con-
tracted with 62.5 mM K+ in the presence of SQ29,548) was
similar in both sides of the DA. In contrast, the relaxing
potency and eYcacy of isoproterenol (Fig. 4b) was signiW-
cantly higher (P < 0.05) in the pulmonary (pD2 7.71, SD
0.26, Emax 117.95%, SD 8.3, n = 6) than in the aortic side
(pD2 7.37, SD 0.15; Emax 72.77%, SD 3.1, n = 6). Forskolin
(Fig. 4c) also induced a higher relaxation in the pulmonary
than in the aortic side of the 19-day DA, but signiWcant
diVerences were only observed with the highest concentra-
tion tested (10 M). Similarly to isoproterenol, the relaxing
potency and eYcacy of milrinone (Fig. 4d) was signiW-
cantly (P < 0.05) higher in the pulmonary (pD2 5.96, SD
0.16, Emax 80.2%, SD 9.8, n = 6) than in the aortic side (pD2
5.0, SD 0.16; Emax 59.2%, SD 14, n = 4). The eVects of mil-
rinone were also studied in the 15-day DA and a similar
signiWcantly higher relaxation was observed in the pulmo-
nary (pD2 5.4, SD 0.18, Emax 77.1%, SD 9.4, n = 6) than in
the aortic side (pD2 4.9, SD 0.17, Emax 47.2%, SD 11,
n = 6). Finally, as shown in Fig. 4e, the contractile potency
and eYcacy of U46619 was also signiWcantly higher
Fig. 2 Concentration-dependent relaxant eVects of prostaglandin E2
(PGE2,) in chicken DA during contraction induced by K+ (62.5 mM,
a), K+ in the presence of the TP receptor antagonist SQ 29,548 (b and
c), or the TP receptor agonist U46619 (0.1 M, d). The organ cham-
bers were areated with 5% O2/90%N2/5% CO2 (a, b, d). The eVect of
diVerent oxygen concentrations on the relaxations induced by PGE2 in
the 19-day DA is depicted in c, in which the DA rings were aerated
with 0% O2/95% N2/5% CO2, or 95% O2/5% CO2. For clarity, the
curve to PGE2 in 5% O2 from panel B is repeated in c (dashed line).
The eVects of the EP receptor antagonist AH6809 (10 M) on PGE2-
induced relaxation is depicted d (19-day DA). * P < 0.05 for diVerence
from the other ages (a, b) and for diVerence from other oxygen concen-
trations (c)
* *

































































Table 1 Concentration-response parameters for relaxant substances in chicken ductus arteriosus
Values are means (SD); n = no. of embryos (arteries), e.p. externally pipped embryos; pD2 = ¡log EC50; Emax, maximal relaxant eVect. The pD2
was not calculated when a non-signiWcant relaxation was observed
* P < 0.05 from both 15 and 19-day old; 9 P < 0.05 from 19-day old; ‡ P < 0.05 for 19 and 21-day old (5% O2 and precontraction with 62.5 mM
KCl)
15-day-old 19-day-old 21-day-old, e.p.
Emax pD2 n Emax pD2 n Emax pD2 n
PGE2 29.79 (20.1) 7.15 (0.43) 10 5.06 (24.0) – 9 4.7 (8.1) – 7
PGE2 (SQ) 64.14 (11.5) 6.45 (0.21) 4 46.89 (24.5) 6.36 (0.06) 8 18.27 (3.7)* 6.19 (0.15) 4
Isoproterenol 120.7 (25.2) 6.63 (0.31)9 8 107.3 (23.8) 7.03 (0.46) 29 64.0 (15.3)* 6.99 (0.26) 12
Forskolin 97.2 (9.5) 5.59 (0.09) 8 124.6 (37.5) 5.58 (0.28) 7 111.7 (21.3) 5.44 (0.05) 8
Milrinone 75.12 (10.1) 5.4 (0.14)‡ 6 86.31 (9.8) 6.0 (0.15) 8 86.16 (19.4) 6.06 (0.18) 8123
138 J Comp Physiol B (2009) 179:133–143(P < 0.05) in the pulmonary than in the aortic side of the
19-day (pulmonary: pD2 6.52, SD 0.15, Emax 1.58 N/m, SD
0.61, n = 6; aortic: pD2 6.1, SD 0.13, Emax 0.34 N/m,
SD 0.18, n = 6) and the 15-day (pulmonary: pD2 6.84, SD
0.185, Emax 0.33 N/m, SD 0.24, n = 6; aortic: pD2 5.3,
SD 0.16, Emax 0.08 N/m, SD 0.06, n = 6) chicken DA.
Discussion
PGE2 plays a major role in prenatal patency and postnatal
closure of the mammalian DA, namely during fetal life by
exerting a potent relaxant eVect (Clyman 2006; Smith
1998), possibly in conjunction with nitric oxide (NO, Coce-
ani et al. 1994; Momma and Toyono 1999; Seidner et al.
2001; Takizawa et al. 2000), and after birth by abruptly
withdrawing its action. We have previously shown that the
transition to ex ovo life is accompanied by dramatic
changes in chicken DA reactivity (Agren et al. 2007, 2008).
In the present paper, we have characterized, for the Wrst
time, the eVects of PGE2 and other drugs acting through the
adenylate cyclase/cAMP pathway on chicken ductal tone.
Our main Wndings are: (1) PGE2 induced an EP receptor-
mediated relaxation of the chicken DA that was partially or
wholly masked by a simultaneous contractile eVect medi-
ated through TP receptors; (2) the relaxant responses
induced by PGE2 and the -adrenoceptor agonist isoprote-
renol, but not those elicited by the adenylate cyclase activa-
tor forskolin or the PDE3 inhibitor milrinone, decreased
with maturation, (3) relaxations to PGE2 are decreased with
increasing oxygen concentrations and (4) the eVects of
PGE2 were similar in the pulmonary and aortic sides of the
DA, whereas isoproterenol and milrinone caused a more
eYcient relaxation in the pulmonary side of the chicken
DA.
As mentioned elsewhere, COX inhibitors did not induce
signiWcant changes in the basal tension of the chicken
(Agren et al. 2007) or the emu (Dzialowski and Greyner
2008) DA and did not alter the vasoactive eVects of other
agonists in the chicken DA (Agren et al. 2007, 2008), sug-
gesting that locally produced PGs are not important media-
tors in the control of ductal tone in these avian species.
However, Dzialowski and Greyner (2008) observed that
exogenous PGE2 relaxed the oxygen-constricted emu DA
with a threshold concentration of 0.1–1 M and a full relax-
ation at 10 M, the highest concentration tested. In the
present paper, we demonstrate that exogenous PGE2 is
indeed a DA vasodilator in the chicken but its relaxant
response is masked by its ability to activate TP receptors.
We found that TP receptor occupancy either by an agonist
Fig. 3 Concentration-depen-
dent relaxant eVects of isoprote-
renol (a, b), forskolin (c, d) and 
milrinone (e) in 15, 19 and 21-
day DA rings aerated with 5% 
O2/90%N2/5% CO2. The eVects 
of the -adrenergic receptor 
blocker propanolol (prop) on 
isoproterenol-evoked relaxation 
are shown in a. b, d Depict the 
eVects of the nonselective COX 
inhibitor indomethacin (10 M), 
the COX-1 inhibitor valeryl 
salicylate (Val. salic., 0.5 mM), 
or the COX-2 inhibitor nimesu-
lide (0.1 M) on the relaxations 
induced by isoproterenol (b) and 
forskolin (d) in 19-day DA. 
Potassium (62.5 mM) was used 
as precontractile agent. 
* P < 0.05 for diVerence in Emax 
from the other ages. ‡ P < 0.05 
for diVerence in Emax from 
19 day. 9 P < 0.05 for diVerence 
in pD2 from the other ages





























































































J Comp Physiol B (2009) 179:133–143 139(U46619) or an antagonist (SQ29,548) results in the
appearance or the increase of the relaxant response to
PGE2. This is consistent with a stimulatory action of PGE2
on TP receptors. The PGE2 promiscuous interaction with
TP receptors, especially at concentrations higher than
1 M, has also been observed in several vascular tissues
including human umbilical arteries (Boersma et al. 1999)
and veins (Daray et al. 2003), human uterine arteries
(Baxter et al. 1995) and aorta of the spontaneously hyper-
tensive rat (Tang et al. 2008). An alternative explanation
for the eVects of SQ29,548 on PGE2-induced relaxation
might be the blockade of a baseline TxA2- or isoprostane-
induced tone (Gonzalez-Luis et al. 2005), allowing greater
relaxatory actions of PGE on its dilatory receptors. How-
ever, this possibility is unlikely, since SQ29,548 have no
eVect on DA mechanical activity, suggesting the lack of
basal release of a TP receptor stimulator.
PGE2-induced relaxation of the chicken DA was abol-
ished by AH6809 suggesting the involvement of EP recep-
tors. However, AH6809 is a non selective EP receptor
antagonist, which may also block DP and TP receptors
(Tang et al. 2008). Accordingly, we observed that AH6809
impaired the contraction induced by U46619. Future func-
tional experiments with more selective EP antagonists, as
well as investigations addressing the expression and bind-
ing activity of prostanoid receptors in the chicken DA are,
therefore, warranted. Nevertheless, we observed that the
relaxant potency and eYcacy of PGE2 in the chicken DA,
even after blocking its eVect on the TP receptor, was very
low. Dzialowski and Greyner (2008) also described a low
relaxant potency of PGE2 in the emu DA. In contrast, PGE1
and PGE2 in the picomolar and low nanomolar range
relaxed the rat, rabbit, pig and lamb DA (Bhattacharya et al.
1999; Clyman et al. 1983, 1980; Smith 1998; Waleh et al.
2004), while the only mammalian species studied where
PGs have not been shown to exert a signiWcant DA relaxa-
tion is the guinea pig (Bodach et al. 1980; Smith 1998).
With our present results we can only speculate about the
functional consequences of the low relaxant potency of
PGE2 in the chicken DA. In the mammalian fetus, circulat-
ing concentrations of PGE2 appear to be of placental origin
(Clyman 2006). To the best of our knowledge, there is no
study in the literature examining prostanoids levels in avian
embryos or the role of the choriallantoic membrane, the
analogous of mammalian placenta, in the production of
prostaglandins. These issues remain to be investigated.
Fig. 4 Heterogeneity of relax-
ant and contractile responses 
along chicken ductus arteriosus 
(DA). Response of segments 
from the pulmonary and aortic 
side of 19-day chicken DA to 
PGE2 (a), isoproterenol (b), and 
forskolin (c), milrinone (d), and 
U46619 (e). The responses to 
milrinone and U46619 in the 
pulmonary and aortic side of 15-
day chicken DA are also shown. 
Relaxations were studied during 
contraction induced by K+ 
(62.5 mM). The TP receptor 
antagonist SQ 29,548 (10 M) 
was present in the experiments 
involving PGE2. The vessels 
were aerated with 5% O2/
90%N2/5% CO2 (pO2 »7 kPa). 
* P < 0.05 for diVerence in Emax 
aortic versus pulmonary side. 
‡ P < 0.05 for diVerence in the 
response to a given concentra-
tion. 9 P < 0.05 for diVerence in 

































































































140 J Comp Physiol B (2009) 179:133–143In mammals, the immature fetal DA is more sensitive
than the late-gestation fetal DA to the relaxing eVects of
PGE2 (Bhattacharya et al. 1999; Clyman et al. 1983, 1980;
Waleh et al. 2004). Herein, we have found that chicken DA
is more sensitive to PGE2 in preterm than in term. The acti-
vation of TP receptors by PGE2 is, at least partially, respon-
sible for these changes with age. Thus, in the absence of TP
antagonist a relaxant response is observed in the 15-day
DA, whereas no relaxation, but contraction, is found in the
19-day DA. However, in the presence of the TP antagonist
the relaxant responses to PGE2 are similar in 15 and
19 days. These results indicate that the contribution of TP
receptor activation in the response to PGE2 increases during
maturation. Accordingly, we have previously demonstrated
a developmental increase in the sensitivity of chicken DA
to the speciWc TP agonist U46619 (Agren et al. 2007). In
addition, from 19- to 21-day there is an additional reduction
in the relaxant responses to PGE2 when SQ29,548 is pres-
ent (i.e., independent of TP receptor activation). Similar to
PGE2, the -adrenoceptor agonist isoproterenol induced
less relaxation in 21-day when compared with 15- or 19-
day DA. PGE2 and isoproterenol induced relaxation, at
least partially, through the adenylate cyclase/cAMP path-
way. Therefore, our results suggest a developmental
decrease in the relaxant eYcacy of this pathway during the
transition to ex ovo life. Nevertheless, direct activation of
adenylate cyclase with forskolin induced a similar relaxa-
tion at all stages of incubation. Thus, the developmental
diVerences in the responses to PGE2 and isoproterenol from
19- to 21-day seem to be due to changes in the coupling
between their receptors and adenylate cyclase. Accord-
ingly, Waleh et al. (2004) found that the EP receptor ago-
nists PGE2 (nonselective), butaprost (EP2 selective) and
M&B 28767 (EP3 selective) produced a greater increase in
cAMP production in the immature than in the mature lamb
DA. However, there were no diVerences between the
immature and mature ductus in the relaxation or cAMP pro-
duction induced by forskolin (Waleh et al. 2004). In the
emu, the other avian DA that has been studied, Dzialowski
and Greyner found similar PGE2-relaxations in the day 45
and day 49 DA (total incubation in the emu: 50 days)
(Dzialowski and Greyner 2008). Unfortunately, they did
not analyze the response to PGE2 of the DA of less mature
emu ductus.
The role of -adrenoceptors in the control of mammalian
DA tone also varies among species (Smith 1998). Infusion
of the -adrenoceptor antagonist propanolol had no eVect
on ductal tone in the in vivo lamb (Friedman et al. 1983).
Furthermore, in the presence of the -adrenoceptor antago-
nist phenoxybenzamine, norepinephrine was able to relax
lamb DA preparations, but the eVects were modest even at
the highest doses (Bodach et al. 1980). In the newborn rat,
propanolol paradoxically delayed DA closure (Arishima
et al. 1995), but it has been suggested that this is secondary
to the eVects of -adrenergic blockade on the perinatal car-
diovascular homeostasis and not due to a direct eVect on
ductal tone (Smith 1998). On the other hand, in the guinea
pig DA, phenoxybenzamine converts the contractile eVect
of norepinephrine to a relaxation and isoproterenol causes a
marked relaxation (Bodach et al. 1980). These results
together with the lack of a prostaglandin-mediated relaxa-
tion could point to a special role for -adrenoceptors in pre-
natal patency in the guinea pig. Herein, we have observed a
similar pattern in the chicken DA. Previously, we demon-
strated that the nonselective adrenergic receptor agonist
norepinephrine and the 1-adrenegic receptor agonist phen-
ylephrine induced a developmentally increased contraction
of the chicken DA. Secretion of catecholamines plays an
important role in several of the adaptations that characterize
the transition of the chicken to ex ovo life (Mulder et al.
2000; Wittmann and Prechtl 1991). The augmentation of
the -adrenergic-mediated contraction and the concomitant
reduction of the -adrenergic-mediated relaxation suggest
an active participation of catecholamines in the closure of
the chicken DA.
The cyclic nucleotides cAMP and cGMP are considered
the main intracellular secondary messengers involved in
smooth muscle relaxation (Omori and Kotera 2007; Rybal-
kin et al. 2003). These molecules are degraded by a family
of enzymes known as phosphodiesterases (PDEs). There
are now known to be 11 diVerent PDE families expressed in
mammalian tissues. Depending on the species, the major
PDEs present in vascular smooth muscle are PDE1, PDE3
and PDE5 (Moreno et al. 2004; Omori and Kotera 2007;
Rybalkin et al. 2003). PDE3 s are termed cGMP-inhibited
cAMP PDEs, whereas PDE5 speciWcally hydrolyzes cGMP
(Moreno et al. 2004; Omori and Kotera 2007; Rybalkin
et al. 2003). We have demonstrated that the chicken DA is
relaxed by the PDE5 inhibitor sildenaWl (Agren et al. 2008)
and by the PDE3 inhibitor milrinone (present work). When
clinically used in premature infants, it appeared that PDE3
inhibitors inhibited closure of the DA (Toyoshima et al.
2006). Toyoshima et al. (2006) demonstrated that the PDE3
inhibitors milrinone and amrinone exhibited dose-depen-
dent DA-dilating eVects in rat fetuses and pups and were
more eVective in the preterm than in the near-term period.
Liu et al. (2008) observed, in the ovine DA, a developmen-
tal increase in the activity and expression of PDE1, 3, 4,
and 5 and reported that the mature ductus required higher
concentrations of PDE1, PDE3, and PDE4 inhibitors to
inhibit its tension to the same extent as in the immature
ductus. In contrast, we have observed a reduced relaxant
eVect of milrinone in the 15-day chicken DA when com-
pared with the 19- or 21-day DA. This reduced response to
milrinone in the 15-day DA was homogeneously present
when segments of the central part, the pulmonary end or the123
J Comp Physiol B (2009) 179:133–143 141aortic end of the DA were analyzed (see below). Our results
might suggest that an increase in PDE3-mediated cAMP
hydrolysis is involved in the age-related decrease of PGE2-
and isoproterenol-induced relaxation observed in the
chicken DA. However, if that was the case, the relaxation
induced by forskolin should also have exhibited a reduction
with maturation.
Another observation of the present work was that hyper-
oxia markedly impaired PGE2-induced relaxation. Previ-
ously, we reported that high oxygen concentrations
decreased the endothelium- dependent and -independent
relaxation induced by, respectively, acetylcholine and the
nitric oxide donor, sodium nitroprusside and increased the
contraction mediated by adrenergic agonists (Agren et al.
2007, 2008). Accordingly, it has been demonstrated that
increasing oxygen tension from fetal to neonatal levels
desensitizes the rabbit DA to a range of vasodilators,
including PGE2 (Smith and McGrath 1991, 1993). Thus the
postnatal increase in O2 is not only one of the main triggers
for constriction of the DA but also has a profound modula-
tory eVect on other vasoactive systems favoring the action
of vasoconstrictors and decreasing the action of vasodila-
tors (Smith 1998).
The chicken DA presents morphological and functional
heterogeneity along its path between the pulmonary artery
and the aorta (Agren et al. 2007; Belanger et al. 2008;
BergwerV et al. 1999, 1996). Thus, the pulmonary side
shows the structure of a muscular artery and responds to O2
with contraction, whereas the aortic part shows the mor-
phology of an elastic artery and relaxes in response to O2
(Agren et al. 2007; Belanger et al. 2008; BergwerV et al.
1999, 1996). In addition, acetylcholine, SNP and the NO-
independent stimulator of sGC BAY 41-2272 induced
larger relaxations in the aortic side of the vessel (Agren
et al. 2008). In the present work, we observed that isoprote-
renol, forskolin, and milrinone evoked signiWcantly larger
relaxations in the pulmonary than in the aortic side of the
chicken DA. This might indicate that the pulmonary side of
the vessel is more sensitive to the vasodilators acting
through cAMP, whereas the aortic side would be more sen-
sitive to cGMP-mediated relaxation. However, and surpris-
ingly, the relaxation evoked by PGE2 was similar in both
regions of the DA. We can only speculate about the nature
of this Wnding. As the contraction induced by the TP recep-
tor agonist U46619 was signiWcantly higher in the pulmo-
nary side, the masking eVect of PGE2-induced TP
stimulation might be smaller in the aortic than in the pul-
monary side. However, the experiments were performed in
the presence of TP antagonism. Another speculation might
be that cAMP-mediated mechanisms are less involved in
the relaxation evoked by PGE2 in the aortic side. In fact, it
has been demonstrated that PGE2 dilates the late gestation
fetal lamb DA through pathways that involve either cAMP
(via EP2 and EP4 receptors) or ATP-dependent potassium
channels (via EP3, Bouayad et al. 2001). However, in the
experiments that compared the pulmonary and the aortic
side of the chicken DA, the vessels were contracted with a
high potassium solution which precluded the relaxation
induced by potassium channels activation.
The heterogeneity of the chicken DA makes the vessel
particularly attractive for the study of its developmental
vascular biology but also poses a methodological problem.
As we mentioned elsewhere, the maximal length of the
rings allowed in the myographs that we used is 2 mm,
whereas the length of the chicken DA is »4–6 mm.
Although the pulmonary and the aortic side of the ductus
can be clearly diVerentiated during the dissection (Agren
et al. 2007), when mounting the central portion of the DA it
is diYcult to control for the exact amount of tissue of each
part that is Wnally present in the myograph. In addition,
putative developmental changes in the proportion between
the two parts of the DA, might inXuence developmental
changes in the responsiveness to the diVerent agonists. This
limitation of our experimental setting was particularly rele-
vant when the response to milrinone was analyzed. We
observed that milrinone-induced relaxation increased with
development but also was higher in the pulmonary than in
the aortic side of the DA. Therefore the reduced relaxation
in the 15-day DA could be related to the presence of higher
amounts of tissue from the aortic side of the vessel. We
controlled for this possibility by analyzing the response to
milrinone in the pulmonary and aortic sides of the 15-day
DA and we observed that the developmental increase was
present in both sides of the vessel.
In summary, with the present and our previous studies
(Agren et al. 2007, 2008), we have completed an extensive
characterization of the pharmacology of the chicken DA
and demonstrated its sensitivity to a wide range of vasoac-
tive agonists including oxygen, prostanoids, potassium
channels blockers, NO, catecholamines, endothelin-1,
adenylate cyclase activators, guanylate cyclase activators
and PDE inhibitors. As occurs in the mammalian, the multi-
plicity of these vasoactive systems seems at odds with the
relatively simple physiological role of the DA (Smith
1998). The main vasoconstrictor of the mammalian DA, the
postnatal increase in oxygen tension, appears to play also a
relevant role in the closure of the chicken DA (Agren et al.
2007; Belanger et al. 2008), whereas the main vasodilator
of the mammalian DA, PGE2, is a weak relaxant agent of
the chicken DA which even stimulates vasoconstrictive
receptors. As the mammalian DA, the chicken DA under-
goes a process of maturation to prepare the task of postnatal
closure. Due to the above similarities and taking into
account the diVerences, the chicken embryo appears as an
extremely interesting model for translational developmen-
tal vascular biology (Sutendra and Michelakis 2007).123
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